{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:13:46Z","timestamp":1788416026089,"version":"build-2803163510"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Foot xerosis in people with diabetes increases the risk of skin fissuring, ulceration and complications like amputation, sepsis and death. Preventive skin care is therefore important, yet evidence-based guidance on the most effective formulations remains limited. This systematic review aimed to identify effective ingredients and formulations to treat diabetic foot xerosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search was conducted in Medline, Cinahl, Embase, CENTRAL and Scopus. Randomized controlled trials (RCTs) involving adults with diabetes and foot xerosis (without ulcers) that compared topical formulations were eligible. Reviewers screened studies, extracted data, assessed risk of bias and certainty of evidence in accordance with Cochrane Intervention Review standards. Outcomes included xerosis severity, skin hydration, skin barrier integrity and adverse events. Meta-analyses of RCTs were conducted. The review was registered in PROSPERO (CRD42024579919).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eleven articles reporting twelve RCTs were included. Functional creams (i.e., base formulations with added ingredients, most commonly humectants, intended to enhance their effect) significantly reduced xerosis severity compared with standard base formulations after both two weeks (standardized mean difference [SMD] -0.58, 95% CI -1.05 to -0.11) and four weeks (SMD -0.30, 95% CI -0.46 to -0.14). The certainty of evidence was moderate. Functional creams significantly increased skin hydration (SMD 0.31, 95% CI 0.11 to 0.52), although the certainty of evidence was low. Creams containing urea were more effective than standard base creams after four weeks (SMD -0.36, 95% CI -0.55 to - 0.17), with high-certainty evidence. Adverse events were rare and mild.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Functional creams, particularly those containing humectants and primarily urea, show greater efficacy than standard bases. However, high-quality randomized controlled trials with long-term outcomes such as risk of foot ulcers are warranted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42024579919<\/jats:ext-link>\n                      , identifier CRD42024579919.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcdhc.2026.1922860","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:23:36Z","timestamp":1788413016000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Moisturizer formulations for diabetic foot xerosis: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.3389","volume":"7","author":[{"given":"Karin","family":"Borgstr\u00f6m","sequence":"first","affiliation":[{"name":"Department of Biomedical Science, Malm\u00f6 University","place":["Malm\u00f6, Sweden"]},{"name":"Biofilms Research Centre for Biointerfaces, Malm\u00f6 University","place":["Malm\u00f6, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Bj\u00f6rklund","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, Malm\u00f6 University","place":["Malm\u00f6, Sweden"]},{"name":"Biofilms Research Centre for Biointerfaces, Malm\u00f6 University","place":["Malm\u00f6, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petri","family":"Gudmundsson","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, Malm\u00f6 University","place":["Malm\u00f6, Sweden"]},{"name":"Biofilms Research Centre for Biointerfaces, Malm\u00f6 University","place":["Malm\u00f6, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ericsson","sequence":"additional","affiliation":[{"name":"Biofilms Research Centre for Biointerfaces, Malm\u00f6 University","place":["Malm\u00f6, Sweden"]},{"name":"Department of Care Science, Malm\u00f6 University","place":["Malm\u00f6, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Acosta","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Malm\u00f6, Lund University","place":["Malm\u00f6, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)67698-2","article-title":"The global burden of diabetic foot disease","volume":"366","author":"Boulton","year":"2005","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.2.217","article-title":"Preventing foot ulcers in patients with diabetes","volume":"293","author":"Singh","year":"2005","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2006.06123.x","article-title":"Xerosis and callus formation as a key to the diabetic foot syndrome: dermatologic view of the problem and its management","volume":"4","author":"Pavicic","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3686","article-title":"The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer","volume":"40","author":"Fitridge","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12490","article-title":"The science behind skin care: moisturizers","volume":"17","author":"Draelos","year":"2018","journal-title":"J Cosmet Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304110-00005","article-title":"Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders","volume":"4","author":"Lod\u00e9n","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000493641","article-title":"Moisturizers versus current and next-generation barrier repair therapy for the management of atopic dermatitis","volume":"32","author":"Elias","year":"2019","journal-title":"Skin Pharmacol Physiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1396-0296.2004.04s1005.x","article-title":"Moisturization and skin barrier function","volume":"17","author":"Rawlings","year":"2004","journal-title":"Dermatol Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1039\/c4sm00137k","article-title":"Stratum corneum molecular mobility in the presence of natural moisturizers","volume":"10","author":"Bj\u00f6rklund","year":"2014","journal-title":"Soft Matter"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2016.06.054","article-title":"The effects of polar excipients transcutol and dexpanthenol on molecular mobility, permeability, and electrical impedance of the skin barrier","volume":"479","author":"Bj\u00f6rklund","year":"2016","journal-title":"J Colloid Interface Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2021.07.012","article-title":"Extraction of natural moisturizing factor from the stratum corneum and its implication on skin molecular mobility","volume":"604","author":"Gunnarsson","year":"2021","journal-title":"J Colloid Interface Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2024.10.006","article-title":"Structure and function of skin barrier lipids: effects of hydration and natural moisturizers in vitro","volume":"123","author":"Sagrafena","year":"2024","journal-title":"Biophys J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1038\/s41598-025-88899-0.","article-title":"Niacinamide and its impact on stratum corneum hydration and structure","volume":"15","author":"Sj\u00f6berg","year":"2025","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2021.12.166","article-title":"Beyond additivity: a mixture of glucose and NaCl can influence skin hydration more than the individual compounds","volume":"613","author":"Sonoki","year":"2022","journal-title":"J Colloid Interface Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cocis.2023.101725","article-title":"The stratum corneum barrier \u2013 from molecular scale to macroscopic properties","volume":"67","author":"Sparr","year":"2023","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.66344\/jpad.v32i2.1876","article-title":"Systematic review and meta-analysis of the effectiveness of urea-based moisturizer on dry skin in diabetes mellitus patients with parameters stratum corneum hydration and xerosis assessment scale","volume":"32","author":"Soesman","year":"2022","journal-title":"J Pak Assoc Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s13047-017-0190-9","article-title":"Moisturizer for the treatment of foot xerosis: a systematic review","volume":"10","author":"Parker","year":"2017","journal-title":"J Foot Ankle Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-025-00814-0","article-title":"Optimal foot skin care for diabetes-related foot ulcer prevention: scoping review","volume":"16","author":"Oe","year":"2025","journal-title":"Diabetol Int"},{"key":"B21","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5","author":"Higgins","year":"2024"},{"key":"B22","first-page":"CRD42024579919","volume-title":"Moisturizer formulations for alleviating diabetes related foot xerosis: systematic review of randomized controlled trials","author":"Borgstr\u00f6m","year":"2024"},{"key":"B23","volume-title":"Methodological expectations of Cochrane intervention reviews (MECIR)","author":"Higgins","year":"2023"},{"key":"B24","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.31222\/osf.io\/v7gm2_v1","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B25","article-title":"Assessing risk of bias in a randomized trial","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5","author":"Higgins","year":"2024"},{"key":"B26","article-title":"Completing Summary of Findings tables and grading the certainty of the evidence","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5","author":"Sch\u00fcnemann","year":"2024"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cesm.70062","article-title":"Split body trials in systematic reviews and meta-analyses: A tutorial","volume":"3","author":"Livingstone","year":"2025","journal-title":"Cochrane Evidence Synth Methods"},{"key":"B28","volume-title":"James Lind Alliance Priority Setting Partnership Guidebook 2025","year":"2025"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14947","article-title":"Research priorities to prevent and treat diabetic foot ulcers: a digital James Lind Alliance Priority Setting Partnership","volume":"39","author":"Kumlien","year":"2022","journal-title":"Diabetes Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-12-16","article-title":"An urea, arginine and carnosine based cream (Ureadin Rx Db ISDIN) shows greater efficacy in the treatment of severe xerosis of the feet in type 2 diabetic patients in comparison with glycerol-based emollient cream: a randomized, assessor-blinded, controlled trial","volume":"12","author":"Federici","year":"2012","journal-title":"BMC Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1037731","article-title":"Use of a urea, arginine and carnosine cream versus a standard emollient glycerol cream for treatment of severe xerosis of the feet in patients with type 2 diabetes: a randomized, 8 month, assessor-blinded, controlled trial","volume":"31","author":"Federici","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903201699","article-title":"Fungal chitin-glucan scaffold for managing diabetic xerosis of the feet in menopausal women","volume":"10","author":"Quatresooz","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"B33","article-title":"Effects of a urea-based moisturizer on foot xerosis in people with diabetes","volume":"11","author":"Baker","year":"2008","journal-title":"Diabetes Foot J"},{"key":"B34","first-page":"44","article-title":"A study to assess a cosmetic product in the treatment of cracked heels among diabetics","volume":"12","author":"Carter","year":"2013","journal-title":"Dermatol Nurs"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2010.12.004","article-title":"Evaluation of the moisturizer P\u00e9dimed\u00ae in the foot care of diabetic patients","volume":"37","author":"Garrigue","year":"2011","journal-title":"Diabetes Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13402","article-title":"Treatment by a moisturizer of xerosis and cracks of the feet in men and women with diabetes: a randomized, double-blind, placebo-controlled study","volume":"34","author":"Gin","year":"2017","journal-title":"Diabetes Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1177\/21501319211068653","article-title":"Implications of a diabetic foot xerosis treatment with an emulsion containing plant-based anionic phospholipids","volume":"13","author":"Glonek","year":"2022","journal-title":"J Prim Care Community Health"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14095","article-title":"Efficacy of an emollient cream in the treatment of xerosis in diabetic foot: a double-blind, randomized, vehicle-controlled clinical trial","volume":"31","author":"Martini","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B39","article-title":"A prospective, randomized, controlled double-blind study of a moisturizer for xerosis of the feet in patients with diabetes","volume":"48","author":"Pham","year":"2002","journal-title":"Ostomy Wound Manage"},{"key":"B40","article-title":"Beneficial effects of a topical foam cream product in a study on subjects with type 1 and type 2 diabetic foot skin xerosis","volume":"27","author":"Schulte-Walter","year":"2018","journal-title":"Diabetes Stoffwechsel Herz"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.02.007","article-title":"The effects of glycols on molecular mobility, structure, and permeability in stratum corneum","volume":"343","author":"Kis","year":"2022","journal-title":"J Control Release"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1080\/000155502753600885","article-title":"A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patients","volume":"82","author":"Lod\u00e9n","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.1007\/BF02505052","article-title":"Urea-containing moisturizers influence barrier properties of normal skin","volume":"288","author":"Lod\u00e9n","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"B44","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jid.2020.03.945","article-title":"Research techniques made simple: randomized controlled trials for topical drugs in dermatology: when and how should we use a within-person design","volume":"140","author":"Leducq","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.03.945","article-title":"Design and methodological issues of within-person (split-body) randomized controlled trials evaluating a topical treatment: a systematic review","volume":"239","author":"Leducq","year":"2023","journal-title":"Dermatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/s0958-2592(03)00047-6","article-title":"Two feet, or one person? Problems associated with statistical analysis of paired data in foot and ankle medicine","volume":"14","author":"Menz","year":"2004","journal-title":"Foot (Edinb)"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1922860\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:23:39Z","timestamp":1788413019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1922860\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":46,"alternative-id":["10.3389\/fcdhc.2026.1922860"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2026.1922860","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1922860"}}